Introduction {#sec1}
============

A woman\'s lifetime risk of acquiring HPV infection is higher than 80%, and most infections occur within 3-4 years of sexual debut \[[@cit0001]\]. The principal burden of HPV infections globally has been cervical cancer. HPV infections are observed in over 99% of patients with cervical cancer \[[@cit0002]\]. Globally, cervical cancer is the fourth most common cancer among women affecting 500,000 women annually. In 2012, globally, there was up to 528,000 new cases of cervical cancer and 266,000 deaths \[[@cit0003]\]. In developing countries, cervical cancer accounts for 12% of female cancers and these contribute 80% of global cervical cancer cases \[[@cit0003]\]. The World Health Organization recommends HPV vaccination for girls aged 9-14 years as the most cost-effective public health intervention against cervical cancer. In Uganda, cervical cancer ranks as the most frequent cancer among women aged between 14 and 15 years. The age-standardised incidence rate of cervical cancer is high at 47.5/100,000 \[[@cit0003]\]. Despite this, many girls and women in Uganda stay without routine HPV vaccination and cervical cancer screenings because of lack of awareness, limited availability of vaccination and screening programs \[[@cit0005], [@cit0006]\]. Therefore more than three-quarters of cervical cancer patients in Uganda report with advanced disease conditions \[[@cit0007]\]. In Uganda, HPV vaccination was first piloted in 2008 in Nakasongola and Ibanda districts. It was later piloted in 12 other districts in 2012. The success of these pilot projects paved the way for countrywide scale-up of HPV vaccination before the end of 2015 and is now integrated into the national routine immunisation program \[[@cit0008]\]. Lira district is one of the first 12 districts where HPV vaccination was piloted. This study assessed the level and the factors associated with uptake of HPV vaccine by female adolescent girls in Lira district, Uganda to inform implementation of the HPV vaccine program in Uganda.

Methods {#sec2}
=======

**Study area and design:** we employed a mixed methods approach in which quantitative and qualitative data were collected using a concurrent triangulation design. By combining quantitative and qualitative data, we sought convergence and corroboration among the different data sources. The multiple perspectives provided an opportunity to develop a complete understanding of the factors associated with uptake of HPV vaccination. This study was conducted in Lira district, Northern Uganda in May 2016. Lira district is one of the 12 districts where the HPV vaccination program was first implemented (piloted) in Uganda in 2012, so the program was four years old at the time of this study.

**Study population:** the study enrolled female adolescents aged 12-17 years because they were expected to have completed the vaccination schedule.

**Quantitative study:** quantitative data were collected in a multistage cross-sectional design. The required sample size of 460 was determined using the formula by Bennett *et al.* (1991) \[[@cit0009]\] for cluster surveys with the following assumptions; a precision of 0.032 as was used in a study by Turner (2003), type I error of 5%, prevalence of uptake at 50% PATH *et al*, (2011) \[[@cit0010]\], 10 households per village and a design effect of 1.9. This study used a three-stage sampling procedure; at the first stage, we randomly selected four sub-counties out of the 13 in the district (i.e, two rural and two urban). At the second stage, we randomly selected two parishes from each of the selected sub-counties. For each parish selected, we randomly selected villages proportionate to the number of villages the parish until the required number of villages was realised. At the third stage, a list of all households with 12-17-year-old adolescent girls was generated for each village. Households from this list were randomly selected until the required sample size was realised for the village. One adolescent was selected from each household.

**Measurements:** the dependent variable was the uptake of HPV vaccine which was categorised into two; fully vaccinated and not fully vaccinated. We determined HPV uptake using respondents\' recall or vaccination cards if were present. An adolescent was considered fully vaccinated if they had received all the three doses of the HPV vaccine. Any adolescent who had received one, two or no dose of HPV vaccine was considered not fully vaccinated. The Independent variables included: individual factors, community factors and health service factors. Individual factors included; sociodemographic characteristics, knowledge about the HPV vaccine and attitudes towards HPV vaccine. We measured knowledge of respondents about the HPV vaccine as a composite variable by asking respondents six questions about the HPV vaccine. The same approach has been used in other studies to measure knowledge levels \[[@cit0011]\] [Table 1](#t0001){ref-type="table"}. The knowledge score ranged from 0-6 depending on whether the respondent had passed or failed the question. We considered scores 4-6 as good knowledge about HPV vaccination and scores 0-3 as poor knowledge \[[@cit0012]\]. We used a three-point Likert scale (2-agree, 1-neither agree nor disagree and 0-disagree) to measure attitudes of respondents towards HPV vaccination using five attitude statements as shown in [Table 2](#t0002){ref-type="table"}. The attitude score ranged from 0-10 depending on whether the respondent agreed or disagreed to the statement. We considered scores 6-10 as positive attitude towards HPV vaccination and scores ≤ 4 as negative attitude \[[@cit0013]\].

###### 

measurement of knowledge levels about the HPV vaccine of female adolescents in Lira District, Uganda

  Knowledge variables                                                   Response   Score
  --------------------------------------------------------------------- ---------- -------
  Had ever heard of the HPV vaccine                                     Yes        1
  No                                                                    0          
  Knew the benefits of receiving the HPV vaccine                        Yes        1
  No                                                                    0          
  Knew the recommended doses of HPV vaccine                             Yes        1
  No                                                                    0          
  Knew the recommended intervals between the doses of the HPV vaccine   Yes        1
  No                                                                    0          
  Knew the target age group for the HPV vaccine                         Yes        1
  No                                                                    0          
  Knew where to access the vaccine from                                 Yes        1
  No                                                                    0          

Total Score = 6, Good knowledge= scores 4-6, Poor knowledge= scores 0-3

###### 

measurement of attitude levels towards the HPV vaccine among female adolescents in Lira District, Uganda

  Attitude statements                                                    Response   Score
  ---------------------------------------------------------------------- ---------- -------
  HPV infections cause cervical cancer                                   Agreed     2
  cervical cancer is a deadly disease                                    Agreed     2
  it is important for young girls to receive the HPV vaccine             Agreed     2
  HPV vaccine is effective in protecting girls against cervical cancer   Agreed     2
  HPV vaccine has no side effects                                        Agreed     2

Total Score = 10, Positive attitudes = scores 6-10, Negative attitudes = scores 0-5

**Data management and analysis:** we reviewed the data for completeness, coded it, and analysed the data using STATA. We computed summary statistics like frequencies, proportions and means of different variables. We then conducted univariable, bivariable and multivariable analysis. At bivariable analysis, we computed prevalence ratios (PR) using a generalised linear model with Poisson family and a log link with robust standard errors as a measure of association because the prevalence of the outcome was above 10%. At multivariable analysis, we included all independent factors with p \< 0.10 at bivariable analysis in the multivariable model to obtain adjusted prevalence risk ratios. We used the backward forward elimination with the logical model building approach of considering factors known from literature that affect HPV vaccine uptake to ascertain the best fitting model.

**Qualitative study:** for the qualitative approach, we used purposive sampling. We conducted 20 in-depth interviews, five from each category of adolescents who had not received, received one, two and three doses respectively. We also conducted five key informant interviews with the district health team members who had an expert opinion about the health service factors that influence uptake of HPV vaccination in Lira district. The district team members included the following: the assistant district health officer for maternal and child health, the district vaccines focal person, district health educator and two sub-county health facility In-charges Qualitative data were transcribed from audio recordings for content analysis. We read the transcripts several times and then coded them to identify recurring themes. We then identified key quotations that represented the central themes on factors influencing uptake of HPV vaccine and presented them in the results as text.

**Ethical considerations:** the study was approved by Makerere University School of Public Health Higher Degree Research and Ethics Committee. We sought permission to conduct the study from the Lira district and community gatekeepers. Voluntary participation in the study was sought using written informed consent.

Results {#sec3}
=======

**Social demographic characteristics of respondents:** a total of 460 respondents participated in the study with a response rate of 100%. The age of respondents ranged from 12 to 17 years with a mean age of 14 years (SD =1.24). The majority of respondents 82.6% (380/460) were living with their parents, and 94% (432/460) were in school. Most of the respondents 79.8% (367/460) had both their parents still alive ([Table 3](#t0003){ref-type="table"}).

###### 

social demographic characteristic of female adolescents aged 12--17 in Lira district, Uganda

  Variable                         Frequency (N=460)   Percentage (%)
  -------------------------------- ------------------- ----------------
  **Age groups**                                       
  12-14                            306                 66.5
  15-17                            154                 33.5
  **Religion**                                         
  Catholic                         186                 40.4
  Protestants                      202                 43.9
  Muslims                          15                  3.3
  Others                           57                  12.4
  **Parent Status**                                    
  Both alive                       367                 79.8
  One alive                        71                  15.4
  Both dead                        22                  4.8
  **Living status**                                    
  Stay with parents                380                 82.6
  Do not stay with parents         80                  17.4
  **Highest level of education**                       
  None                             10                  2.2
  Primary level                    252                 54.8
  Secondary Ordinary level         198                 43.0
  **Current education status**                         
  At school                        432                 93.9
  Not at school                    28                  6.1
  **Residence**                                        
  Urban                            246                 53.5
  Rural                            214                 46.5

Mean age of 13.97 (standard deviation of 1.24)

**Level of HPV vaccine uptake:** out of the 460 respondents interviewed, 49.6%, (228/460) had not received any dose of HPV vaccine, 18.0% (83/460) had received one dose, 14.8% (68/460) had received two doses, and 17.6% (81/460) had completed all the three doses. 0ut of the 232 respondents who had initiated on the vaccine, 180 (77.6%) had received it from school. The level of uptake was 17.6% ([Table 4](#t0004){ref-type="table"}).

###### 

level of uptake, vaccination status and place of vaccination among female adolescents aged 12--17 in Lira district

  Variable                                                          Frequency (N = 460)   Percentage (%)
  ----------------------------------------------------------------- --------------------- ----------------
  **Had ever visited the HPV vaccination site**                                           
  Yes                                                               250                   54.4
  No                                                                210                   45.7
  **Number of doses received**                                                            
  None                                                              228                   49.6
  One                                                               83                    18.0
  Two                                                               68                    14.8
  Three                                                             81                    17.6
  **Level of uptake**                                                                     
  Fully vaccinated                                                  81                    17.61
  Not fully vaccinated                                              379                   82.39
  **Place of vaccination for those who had ever been vaccinated**                         
  School only                                                       180                   77.6
  Health facility only                                              32                    13.8
  Both school and health facility                                   16                    6.9
  HPV community outreach only                                       04                    1.7

**Knowledge about the HPV vaccination:** More than half (57.10%, 265/460) of the respondents had heard about the HPV vaccine. Half (50.87%, 234/460) of the respondents knew at least one benefit of receiving the HPV vaccine. More than half of the respondents (61.30%, 282/460) did not know the recommended doses of the HPV vaccine and the majority (81.09%, 373/460) of respondents did not know the recommended intervals between the HPV vaccine doses. More than half (53.70%, 247/460) of the respondents did not know the targeted age group for the HPV vaccine, and only 51.74% (238/460) of the respondents knew where to access the HPV vaccines. Overall, more than half of the respondents (56.09%, 258/460) had poor knowledge about the HPV vaccine ([Table 5](#t0005){ref-type="table"}).

###### 

knowledge of respondents about the HPV vaccine among female adolescents in Lira District, Uganda

  Variable                                                           Frequency   Percentage(%)
  ------------------------------------------------------------------ ----------- ---------------
  **Heard of HPV vaccine**                                                       
  Yes                                                                265         57.10
  No                                                                 195         42.39
  **Knew at least one benefit of the HPV vaccine**                               
  Yes                                                                234         50.87
  No                                                                 226         49.13
  **Knew the recommended doses of the HPV vaccine**                              
  Yes                                                                178         38.70
  No                                                                 282         61.30
  **Knew the recommended intervals between the HPV vaccine doses**               
  Yes                                                                87          18.91
  No                                                                 373         81.09
  **Knew the target age group for HPV vaccines**                                 
  Yes                                                                213         46.30
  No                                                                 247         53.70
  **Knew the where to access the HPV vaccine from**                              
  Yes                                                                238         51.74
  No                                                                 222         48.26
  **Respondent's overall level of knowledge about HPV vaccine**                  
  Good                                                               202         43.91
  Poor                                                               258         56.09

Knowledge score ranged from 0--6, Good Knowledge = scores 4-6, Poor knowledge = scores 0-3

**Attitudes towards HPV vaccination:** the majority 70% (322/460) of the respondents agreed that HPV infections cause cervical cancer. Most of the respondents (93.7%, 431/460) agreed that cervical cancer is a deadly disease. A large proportion (88.7%, 408/460) of the respondents agreed that it is important for young adolescents to receive the HPV vaccine. Most (72.17%, 332/460) of the respondents agreed that the HPV vaccine is effective in protecting against cervical cancer. More than half (55.22%, 254/460) of the respondents agreed that the HPV vaccine has no side effects. The respondents who disagreed with the statement of HPV vaccine having no side effects gave side effects like; the injection is painful and it causes pain in the upper arms. Overall, the majority (83.48%, 384/460) of respondents had positive attitudes towards the HPV vaccine

Factors independently associated with uptake of HPV vaccine among female adolescents aged 12-17 in Lira district {#sec3.1}
----------------------------------------------------------------------------------------------------------------

**Individual factors independently associated with uptake of HPV vaccine:** the proportion of adolescent fully vaccinated with the HPV vaccine was 48% more among adolescents who had attained a secondary ordinary level of education compared to those who had attained an education level of primary and below (Adjusted Prevalence ratio (PR) 1.48, 95%CI 1.11-1.97). Having a positive towards the HPV vaccine was a strong predictor of HPV vaccine uptake. The prevalence of uptake of HPV vaccine was 3 times higher among adolescents with positive attitudes towards the vaccine compared to those with negative attitudes (adjusted PR 3.46, 95%CI 1.70-7.02) adolescents who had received the HPV vaccine doses from more than one vaccination site had a 59% higher prevalence of HPV vaccine uptake compared to those who had received all the HPV vaccine doses from one vaccination site (adjusted PR 1.59, 95%CI 1.10-2.28). This is also revealed in a statement by one of the interviewed adolescents; *\"At school, I got only two doses, but my mother took me to the hospital where I got the third dose\" (In-depth interview 13).* The qualitative results from the in-depth interviews revealed that knowledge about HPV vaccination was a predictor of HPV vaccine uptake. Adolescents who had not taken any vaccination dose were not aware of the HPV vaccine and did not know the benefits. For example, most of them commonly said that; *\"I am not aware of the HPV vaccine, and I don\'t know what it protects against\"* (In-depth interview 1). However, most of the adolescents who had received one dose of the HPV vaccine were aware of the HPV vaccine but did not know the right doses and intervals between the doses. *\"The teachers told us that the HPV vaccine is important and protects against cervical cancer but did not explain to us well the intervals and doses\"* (In-depth interview 7) ([Table 6](#t0006){ref-type="table"}).

###### 

factors independently associated with uptake of HPV vaccine among female adolescents aged 12-17 in Lira district

  Variable                                                                                 HPV vaccine uptake   Un adjusted PR(95%CL)   P- value                                                  Adjusted PR(95%CL)   P-value                                                 
  ---------------------------------------------------------------------------------------- -------------------- ----------------------- --------------------------------------------------------- -------------------- ------------------------------------------------------- ---------
  **Highest level of education**                                                                                                                                                                                                                                               
  Secondary 0' level                                                                       46(23.23)            152(76.77)              1.74(1.17-2.59)[\*\*](#tf6-2){ref-type="table-fn"}        0.007                1.48(1.11-1.97)[\*\*](#tf6-2){ref-type="table-fn"}      0.008
  **Knowledge about HPV vaccine**                                                                                                                                                                                                                                              
  Knowledgeable                                                                            55(27.23)            147(72.77)              2.70(1.76 - 4.15)[\*\*\*](#tf6-3){ref-type="table-fn"}    \<0.001              1.13(0.60-2.13)                                         0.706
  **Respondent received all the vaccine doses from one site**                                                                                                                                                                                                                  
  Yes                                                                                      11(68.75)            5(31.25)                2.12(1.45 - 3.11)[\*\*\*](#tf6-3){ref-type="table-fn"}    \< 0.001             1.59(1.10-2.28)[\*](#tf6-1){ref-type="table-fn"}        0.013
  Attitude towards HPV vaccine                                                                                                                                                                                                                                                 
  Positive                                                                                 57(14.84)            327(85.16)              0.47(0.31 - 0.71)[\*\*\*](#tf6-3){ref-type="table-fn"}    \<0.001              3.46(1.70-7.02)[\*\*](#tf6-2){ref-type="table-fn"}      0.001
  **Respondent has ever been encouraged by a community member to go for HPV vaccine**                                                                                                                                                                                          
  Health worker                                                                                                                                                                                                                                                                
  Yes                                                                                      40(37.38)            67(62.62)               3.22(2.20 -- 4.70)[\*\*\*](#tf6-3){ref-type="table-fn"}   \< 0.001             1.55(1.15-2.11)[\*\*](#tf6-2){ref-type="table-fn"}      0.005
  VHT                                                                                                                                                                                                                                                                          
  Yes                                                                                      3(50.00)             3(50.00)                2.91(1.27 -- 6.65)[\*\*](#tf6-2){ref-type="table-fn"}     0.011                3.47(1.50-8.02)[\*\*](#tf6-2){ref-type="table-fn"}      0.004
  **HPV vaccine community outreaches conducted**                                                                                                                                                                                                                               
  Yes                                                                                      16(28.07)            41(71.93)               1.74(1.09 -- 2.79)[\*](#tf6-1){ref-type="table-fn"}       0.021                1.47(1.02-2.12)[\*](#tf6-1){ref-type="table-fn"}        0.037
  **Vaccines were available at HPV vaccination site on all respondent's visits**                                                                                                                                                                                               
  Yes                                                                                      62(70.45)            26(29.55)               6.01(3.85 -- 9.37)[\*\*\*](#tf6-3){ref-type="table-fn"}   \< 0.001             4.84(2.90-8.08)[\*\*\*](#tf6-3){ref-type="table-fn"}    \<0.001
  **Health workers were available at HPV vaccination site on all respondent's visits**                                                                                                                                                                                         
                                                                                                                                                                                                                                                                               
  Yes                                                                                      73(35.27)            134(64.73)              1.90(0.99 -- 3.64)                                        0.055                0.84(0.44-1.57)                                         0.578
  **Respondent received full information about the HPV vaccine at the vaccination site**                                                                                                                                                                                       
  Yes                                                                                      65(50.78)            63(49.22)               3.87(2.38 -- 6.31)[\*\*\*](#tf6-3){ref-type="table-fn"}   \< 0.001             1.90(1.26 -- 2.85)[\*\*](#tf6-2){ref-type="table-fn"}   0.002

Log likelihood = -120.992, Akaike's information criterion (AIC) = 1.16, Availability of vaccines at the vaccination site on all visits, Attitude towards HPV vaccine, Highest level of education, Receiving the HPV vaccine doses from more than one site, Encouragement from health worker and VHT to go for the HPV vaccine, conducting community outreaches & Receiving full information about the HPV vaccine at the vaccination site. \*Statistically significant at P\<0.05

P\< 0.01

P\< 0.001

**Community factors independently associated with uptake of HPV vaccine:** uptake of HPV vaccine was two times higher among adolescents who had been recommended or encouraged to go for the HPV vaccine by health worker compared to those who had not been recommended or encouraged by a health worker to go for the HPV vaccine (adjusted PR 1.55, 95%CI 1.15-2.11). The prevalence of uptake of HPV vaccine was three times higher among adolescents who had been encouraged by a village health team member(VHT) to go for HPV vaccination compared to those who had not been encouraged a VHT (adjusted PR 3.47, 95%CI 1.50-8.02). There was a 47% higher prevalence of uptake of HPV vaccine among adolescents who reported that HPV vaccine community outreaches were conducted in their residences compared to those who reported that the outreaches were not conducted in their residences (Adjusted PR 1.47, 95%CI 1.02-2.12).

**Health service factors independently associated with uptake of HPV vaccine:** the prevalence of uptake of the HPV vaccine was five times higher among adolescents who reported that the vaccines were available at HPV vaccination site at all their visits compared to those who reported that the vaccines were not available at all visits (Adjusted PR 4.84, 95% CI 2.90-8.08). This result is corroborated by key informants as one of them stated that; *\"At first the vaccines were available but during the last lot, the vaccines became unavailable at the different vaccination sites because of inconsistent supply from the national medical store\"* (Key informant interview 1). Qualitative results further revealed that there was also a challenge of lack of sufficient funds to facilitate the transport/delivery of vaccines at the different vaccination sites and the health workers responsible for vaccinating the girls *\"Vaccines were sent without financial support so we had to divert some primary health care funds to facilitate those health workers who vaccinated in schools and community outreaches\"* (Key informant interview 2). The prevalence of uptake of HPV vaccine was 90% higher among adolescents who received full information about the HPV vaccine at the vaccination site compared to those who did not receive full information (adjusted PR 1.90, 95%CI 1.26-2.85).

Discussion {#sec4}
==========

The study estimated the level of uptake of HPV vaccination at 18% which is below the targeted coverage of 80% required to eliminate common serotypes (i.e., 16 and 18) from targeted populations \[[@cit0014]\]. Our result is consistent with results from a study which was conducted among 10th-grade students in Berlin, Germany, 2010. In this study, HPV-vaccine uptake was low. 41.0% of respondents had received the recommended three HPV-vaccine doses \[[@cit0015]\]. Our findings reveal that attaining an education level of secondary is associated with uptake of HPV vaccine. The findings are in line with the recommendations from the World Health Organization of the vaccine targeting girls who have not started sexual debut. Most girls at secondary school level have already started sexual debut, so it is very important for them to complete the HPV vaccination before they start secondary education. Although most of the girls in Uganda do not start having sex until after they are 16.8 years of age \[[@cit0016]\], it\'s important that they are protected against the HPV infection in their early teenage years \[[@cit0017]\]. As indicated in the Andersen and Newman 1995 behavioural model, a positive assessment of participating in a healthy behaviour is an attraction influence towards practising that behaviour and individuals\' willingness to undertake the behaviour. This model may partly explain our finding of an association between having a positive attitude towards the HPV vaccine and uptake of the vaccine in Lira district. Similar associations have been reported by a study conducted among 10th-grade students in Berlin, Germany, where findings revealed that the odds of being fully vaccinated with HPV vaccine decreased with a negative attitude toward vaccinations \[[@cit0015]\]. Interestingly, we found that receiving the HPV vaccine doses from more than one vaccination site was also a major predictor of complete HPV vaccination status. Vaccination efforts at some of the HPV vaccination settings can potentially have a markedly greater impact on overall adolescent-immunisation rates than could those at other settings \[[@cit0018]\].

A study by Ladner (2012) in the lowest income countries to assess eight HPV vaccination programs that used different modes of HPV vaccination showed that mixed models comprising school and health facility-based vaccination had better overall performance compared to models using just one of the methods \[[@cit0019]\]. In Lira district, using mixed models of HPV vaccine delivery were important in addressing missed opportunities of receiving HPV vaccination among adolescents. In our study, the prevalence of HPV vaccine uptake was higher among adolescents who had been encouraged by a health worker or a village health team member to go for HPV vaccination. This result is consistent with findings from a study by Donahue (2015) about HPV vaccine initiation among 9-13-year-olds in the United States. Findings from that study revealed that the strength of health provider recommendation regarding HPV vaccination was a particularly salient predictor of HPV vaccine initiation. Mothers were 21 times more likely to report initiation if they reported that their child´s healthcare provider discussed and recommended HPV vaccination for their child \[[@cit0020]\]. The success of HPV vaccine delivery depends on high community awareness through Information, education, communication activities as well as counselling \[[@cit0021]\]. Community health workers are noble agents of behavioural change and play a key role in the extending formal health services \[[@cit0022]\]. Therefore engaging community health workers/VHTs in community HPV mobilisation and sensitisation activities can increase acceptability of the HPV vaccine by adolescents and their parents since they are more trusted by the community members \[[@cit0023]\]. Furthermore, we found out that there was a 47% higher prevalence of HPV vaccine uptake among adolescents who reported that HPV vaccine community outreaches were conducted in their residences. This result is in agreement with results from a project by PATH (2011) in Nakasongola district, Uganda where parents reported that they were initially reluctant to have their daughters vaccinated because they did not know about cervical cancer or understand the purpose of the HPV vaccines. As they learned more from the community outreaches, they became less reluctant \[[@cit0008]\].

Findings from our study revealed that availability of HPV vaccines at vaccination sites on all adolescents\' visits is associated with higher prevalence. This result is consistent with a study done by Small (2012) \[[@cit0024]\] which evaluated the impact of HPV vaccine availability on uptake among 19- to 26-year-old female patients of Planned Parenthood of Mid and South Michigan before and after the vaccine became available at the health centre. Availability of the HPV vaccine increased vaccine uptake from 11% before clinic availability to 16% after availability. Therefore, increasing the availability of the HPV vaccine at vaccination sites substantially improves HPV vaccine uptake among clients. However, improving the availability of the HPV vaccines alone is not sufficient enough for a substantial increase in uptake. Issues of accessibility, including cost and provider recommendation, must also be addressed \[[@cit0025]\]. Obtaining full information about the HPV vaccine at vaccination sites was positively associated with uptake of the vaccine. This result is consistent with results from a study by Kessels \[[@cit0026]\] to determine factors associated with HPV vaccine uptake among teenage girls. Results revealed that higher vaccine uptake was associated with having a healthcare provider as a source of information \[[@cit0026]\]. The major limitation of our study was that the assessed level of uptake might not necessarily explain the efforts of those that received only one or two doses without completing the third dose. Given the fact that we defined the uptake variable in this study as a binary outcome (i.e, fully vaccinated and not fully vaccinated). In our study, there was a possibility of poor recall in remembering the dates on which the vaccines were administered and the durations between each dose. Poor recall was minimised by cross-checking on the vaccination cards if available. The cross-sectional design that was employed limits the making of causal inferences about the main outcome and independent variables.

Conclusion {#sec5}
==========

We found out that the uptake of HPV vaccine was low. Factors found to be associated with HPV vaccine uptake included: attaining an education of secondary ordinary level, positive attitude towards the vaccine, receiving vaccine doses from more than one site and encouragement from Health workers and Village Health Teams. Other factors associated with uptake of HPV vaccine included; participating in community outreaches, availability of vaccines and receiving full information about the vaccine.

**Recommendations:** we recommended the ministry of health, Uganda to; conduct massive HPV vaccination community sensitisations to build positive attitudes, conduct HPV vaccination community outreaches and to ensure regular availability of vaccines at the vaccination sites. Further studies should also be conducted about the timeliness of HPV vaccinations among female adolescents to see the factors associated with untimely uptake of HPV vaccine doses and the implications of not receiving the doses in the correct intervals.

**Operational definitions:** human papillomavirus vaccine is the vaccine that protects against human papillomavirus which is known to prevent cervical cancer and other HPV infections in women. HPV vaccine uptake was defined as being fully vaccinated with all the three doses of HPV vaccine. Knowledge is the familiarity with information, facts, descriptions, or skills acquired through experience or education about cervical cancer and HPV vaccination. Attitude is a set of health beliefs that determine or guide individual behaviours/conduct. A household consisted of a person or group of persons, related or unrelated, who lived together in the same dwelling unit, who acknowledged one adult male or female as the head of household, who shared the same meals and living arrangements and were considered as one unit.

What is known about this topic {#sec5.1}
------------------------------

-   The study assessed different factors that hinder timely uptake of the HPV vaccine for instance poor attitudes towards the vaccine some of which were already known.

What this study adds {#sec5.2}
--------------------

-   The study adds an in-depth understanding of the importance of timely vaccination with HPV vaccine and the implications of not receiving the vaccine in time.
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